| 1 | 9 Meters Biopharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 2 | Acer Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 3 | Actavia Life Sciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 4 | Active Fine Chemicals Ltd (Bangladesh) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 5 | Adhera Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 6 | Aktsnrny Krgnsky bshchstv Mdtsnskkh (Russia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 7 | Albert Labs International Corp (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 8 | AliveDx Suisse S.A. (Switzerland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 9 | American Bio Medica Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 10 | Apollon Formularies PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 11 | Applied Molecular Transport Inc. (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 12 | Athersys Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 13 | Ayala Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 14 | BELLUS Health Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 15 | Bharat Immunologicals&Biologcls Corp Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 16 | Biosintez PAO (Russia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 17 | Boehringer Ingelheim GmbH (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 18 | Braxia Scientific Corp (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 19 | Calithera Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 20 | CH Boehringer Sohn AG & Co KG (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 21 | Chembio Diagnostics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 22 | China Health Industries Holdings, Inc. (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 23 | CMIC Holdings Co Ltd (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 24 | Colabs Int'l Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 25 | ContraFect Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 26 | CTI BioPharma Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 27 | Dal'khimfarm OAO (Russia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 28 | Deciphera Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 29 | DMK Pharmaceuticals Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 30 | Elysium Pharmaceuticals Ltd. (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 31 | Endo International PLC (Ireland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 32 | Eom Pharmaceutical Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 33 | EQRx Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 34 | Farmak AT (Ukraine) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2021 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 35 | Farmsintez PAO (Russia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 36 | Farmstandart-Tomskkhimfarm OAO (P) (Russia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 37 | FUREN Group Pharmaceutical Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 38 | Gelesis Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 39 | Genocea Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 40 | Glaxo Smithkline Consumer Nigeria PLC (Nigeria) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 41 | GlobeStar Therapeutics Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 42 | Haemato AG (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 43 | Horizon Therapeutics PLC (Ireland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 44 | ImmunoGen, Inc. (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 45 | Infinity Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 46 | Innovation Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 47 | IntelGenx Technologies Corp. (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 48 | Intellipharmaceutics International Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 8/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 49 | Jadran Galenski Laboratorij dd (Croatia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 50 | Jilin Zixin Pharmaceutical Ind. Co., Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 51 | KaiBioTech Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 52 | Karo Healthcare AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 53 | Kolinpharma SpA (Italy) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 54 | Kyivmedpreparat AT (Ukraine) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2020 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 55 | Labomar SpA (Italy) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 56 | Lansen Pharmaceutical Holdings Limited (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 57 | LFB S.A. (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2016 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 58 | Lucy Scientific Discovery Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 59 | Med X Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 60 | Melodiol Global Health Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 61 | Mercury Pharma Group Ltd (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 62 | Merrimack Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 63 | Mindset Pharma Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 64 | Mithra Pharmaceuticals SA (Belgium) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 65 | Neubase Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 66 | NeutriSci International Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 67 | Nichi-iko Pharmaceutical Co., Ltd. (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 68 | North Sur Resources Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 69 | Odonate Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2021 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 70 | Origin Life Sciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 71 | Paion AG (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 72 | Panacea Life Sciences Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 73 | Parenteral Drugs (India) Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 74 | Pcas SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 75 | Petro Usa Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 76 | Pharmacare PLC (Palestinian territories) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2021 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 77 | Pharnext SCA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 78 | Pierrel S.p.A. (Italy) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 79 | Probiotec Limited (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 80 | Procaps Group SA (Luxembourg) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 81 | Q BioMed Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 2/28/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 82 | Reata Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 83 | Rebus Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 84 | Redwood Pharma AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 85 | RegeneRx Biopharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 86 | Respirerx Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 87 | Reunion Neuroscience, Inc. (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 88 | RLS Global AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 89 | Sangui Biotech International Inc (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 90 | Satsuma Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 91 | Selectimmune Pharma AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 92 | Sharon Bio-Medicine Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 93 | Sigilon Therapeutics, Inc. (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 94 | Sinclair Pharma Ltd (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 95 | Sio Gene Therapies Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 96 | Spectrum Pharmaceuticals, Inc. (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 97 | Squarex Pharmaceutical Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 98 | Sunwin Stevia International Inc (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 10/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 99 | TAISHO PHARMACEUTICAL HOLDINGS Co Ltd (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 100 | Taro Pharmaceutical Industries Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 101 | Theradiag SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 102 | Thorne HealthTech Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 103 | TV Pharm Pharmaceutical JSC (Vietnam) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 104 | Vilin Bio Med Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens |